P/B
19,4
Cencora
Cencora is one of three leading domestic pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health hold over 90% share of the US pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.
Cencora is one of three leading domestic pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health hold over 90% share of the US pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.
$59.1B
Market Cap • 9/24/2026
2001
(25 years)
Founded
1995
(31 years ago)
IPO
NYSE
Listing Exchange
United States
Country
S&P500 Participant
Index Composite • 2026
Valuation
P/S
0,2
P/EBITDA
14,4
P/OCF
12,3
P/FCF
14,6
P/E
23
BVPS
15,6
EPS
13,5
Market Cap
Market Cap
59,1B
EV
68,2B
EV/Revenue
0,2
EV/EBITDA
16,6
EV/EBIT
22,4
Payout
Dividend Per Share
2,4
Dividend Yield
0,8%
Buyback Yield
1,8%
Total Yield
2,6%
Dividend Yield 5Y
0,8%
Payout
17,8%
Retained Earnings
9,1B
Profitability
Gross Margin
4%
EBITDA Margin
1,2%
EBIT Margin
—
Net Margin
—
D&A/EBITDA
25,3%
R&D/Revenue
0%
Capex/Revenue
0,2%
Capex/D&A
71,2%
Capex/OCF
15,8%
SBC/OCF
3,1%
% PPE
3,4%
% Goodwill
19,7%
ROE
96,9%
ROIC
8,2%
Growth
CAGR Revenue 5Y
10,2%
CAGR OCF 5Y
10,3%
Leverage
N.D./EBITDA
2,2
Debt/Equity
0%
Current Ratio
0,9
Quick Ratio
0,5
Interest Coverage
705,1%
Premium
- Unrestricted access
- Unlimited data history
- Analysis videos
- Quarterly highlights
- Customizable financials table
- Ranking
- Discussions
...and much more!